AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION
Product details
Registration number: SIN15411P
Classification: General Sale List
Active ingredients:
- Alanine
- Arginine
- Aspartic acid
- Disodium phosphate dodecahydrate
- Glutamic acid
- Glycine
- Histidine
- Isoleucine
- Leucine
- Lysine hydrochloride
- Magnesium chloride hexahydrate
- Methionine
- Phenylalanine
- Potassium acetate
- Proline
- Serine
- Sodium acetate trihydrate
- Sodium hydroxide
- Threonine
- Tryptophan
- Tyrosine
- Valine
Strength:
- 10.50g/1000ml
- 11.50g/1000ml
- 5.60g/1000ml
- 3.581g/1000ml
- 7.20g/1000ml
- 12.00g/1000ml
- 3.00g/1000ml
- 5.00g/1000ml
- 8.90g/1000ml
- 8.56g/1000ml
- 0.508g/1000ml
- 4.40g/1000ml
- 4.70g/1000ml
- 2.453g/1000ml
- 5.50g/1000ml
- 2.30g/1000ml
- 2.858g/1000ml
- 0.360g/1000ml
- 4.20g/1000ml
- 1.60g/1000ml
- 0.40g/1000ml
- 6.20g/1000ml
Dosage form: INFUSION, SOLUTION
Route: INTRAVENOUS
Registrant: B. BRAUN SINGAPORE PTE LTD
ATC code: B05BA10
HSA approval date: 23 January 2018
Manufacturer(s): B. Braun Melsungen AG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15411P
Classification: General Sale List
What active ingredients and strength are recorded for AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Alanine
- Arginine
- Aspartic acid
- Disodium phosphate dodecahydrate
- Glutamic acid
- Glycine
- Histidine
- Isoleucine
- Leucine
- Lysine hydrochloride
- Magnesium chloride hexahydrate
- Methionine
- Phenylalanine
- Potassium acetate
- Proline
- Serine
- Sodium acetate trihydrate
- Sodium hydroxide
- Threonine
- Tryptophan
- Tyrosine
- Valine
Strength:
- 10.50g/1000ml
- 11.50g/1000ml
- 5.60g/1000ml
- 3.581g/1000ml
- 7.20g/1000ml
- 12.00g/1000ml
- 3.00g/1000ml
- 5.00g/1000ml
- 8.90g/1000ml
- 8.56g/1000ml
- 0.508g/1000ml
- 4.40g/1000ml
- 4.70g/1000ml
- 2.453g/1000ml
- 5.50g/1000ml
- 2.30g/1000ml
- 2.858g/1000ml
- 0.360g/1000ml
- 4.20g/1000ml
- 1.60g/1000ml
- 0.40g/1000ml
- 6.20g/1000ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION?
According to the HSA dataset updated 7 August 2026:
Registrant: B. BRAUN SINGAPORE PTE LTD
Which manufacturers and countries are listed for AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): B. Braun Melsungen AG
Manufacturing country/countries: GERMANY
Where can I look up AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15411P or the exact product name AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION. The general register link does not preselect this product.
What are the source dates for this AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this AMINOPLASMAL B.BRAUN 10% E SOLUTION FOR INFUSION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15411P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)